Crohn's Disease Clinical Trials in Tampa, Florida

7 studies are recruiting for crohn's disease in Tampa, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinica…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    USF Health Carol and Frank Morsani Center for Advanced Healthcare ( Site 5039), Tampa, Florida
    Locations
    499 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06430801 on ClinicalTrials.gov

  2. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual …

    Stage
    Phase 4
    Ages
    18 to 70
    Site
    Alliance Clinical Research of Tampa, LLC, Tampa, Florida
    Locations
    48 in total
    Run by
    Takeda

    See if you can join NCT06045754 on ClinicalTrials.gov

  3. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study i…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    USF Health Morsani Center for Advanced Healthcare, Tampa, Florida
    Locations
    190 in total
    Run by
    Takeda

    See if you can join NCT06233461 on ClinicalTrials.gov

  4. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 …

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    NMC Research LLC - Site Number: 8400033, Tampa, Florida
    Locations
    301 in total
    Run by
    Sanofi

    See if you can join NCT07184931 on ClinicalTrials.gov

  5. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are available but do not work…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Gcp Clinical Research /ID# 278126, Tampa, Florida
    Locations
    255 in total
    Run by
    AbbVie

    See if you can join NCT06548542 on ClinicalTrials.gov

  6. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include: The study duration may be up to 286 weeks including: * 40-…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    NMC Research LLC-Site Number: 8400033, Tampa, Florida
    Locations
    35 in total
    Run by
    Sanofi

    See if you can join NCT07184944 on ClinicalTrials.gov

  7. A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

    The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to vedolizumab only (also called monotherapy) in adults with moderately or severely active Crohn's Diseas…

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    USF Health Morsani Center for Advanced Healthcare, Tampa, Florida
    Locations
    138 in total
    Run by
    Takeda

    See if you can join NCT06227910 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.